| Literature DB >> 21224926 |
R Karunanithi1, S Ganesan, T M R Panicker, M Paul Korath, K Jagadeesan.
Abstract
The in vivo evaluation of trabecular bone structure could be useful in the diagnosis of osteoporosis for the characterization of therapeutic response and understanding the role of parameters other than bone mineral density (BMD) in defining skeletal status. This study was made to evaluate changes taking place in the trabecular architecture of bone with age and menopausal status in women. The findings are compared with the femoral neck bone as well as the trochantar bone mineral density determined by dual energy X-ray absorptiometry (DXA), which is a standard reference test for evaluation of osteoporosis. Seventy females were recruited for the study, 25 premenopausal (mean age ± SD: 39.4 ± 3.8) and 45 postmenopausal (mean age ± SD: 57.9 ± 7.9) women. The right femoral neck bone mineral density was measured for them by dual energy X-ray absorptiometry (DXA). For the same individuals, lateral view radiographs of the right calcaneum were taken as well. The radiographs were digitized and the region of interest (ROI) of 256 × 256 pixels was selected, the run length matrix was computed for calculating seven parameters [Table 1] and the two dimensional fast Fourier transform of the image was calculated. Using the FFT, the power spectral density (PSD) was derived and the root mean square (RMS) value was determined. Our results confirm that age has a significant influence on the texture of the trabecular bone and bone mineral density.Entities:
Keywords: Bone mineral density; osteoporosis; texture analysis; trabecular architecture
Year: 2007 PMID: 21224926 PMCID: PMC3014101 DOI: 10.4103/0971-6203.37481
Source DB: PubMed Journal: J Med Phys ISSN: 0971-6203
Figure 1The mass attenuation coefficient versus X-ray photon energy
Assessment of bone mineral density by dual energy X-ray absorptiometry in osteoporosis (diagnostic categories expressed as T-scores)
| Normal bone density | Patient BMD is greater than 1 SD below young adult reference mean BMD (T-score > −1). |
| Osteopenia | Patient BMD is between 1 SD and 2.5 SD below young adult reference mean BMD (T-score < −1 and > −2.5). |
| Osteoporosis | Patient BMD is 2.5 SD or more below young adult reference mean BMD (T-score < 2.5). |
| Severe osteoporosis | Patient BMD is 2.5 SD or more below young adult reference mean BMD with fragility fractures. |
Figure 2The region of Interest (ROI) cropped at posterior compressive trabecular network
Texture parameters and the formulae derived from gray level run length matrix
| Short runs emphasis (SRE) | 1/S S r (j | θ)/j2 |
| Long runs emphasis (LRE) | 1/S S r (j | θ) j2 |
| Gray level non-uniformity (GLN) | 1/S S g (i | θ)2 |
| Run-length non-uniformity (RLN) | 1/S S r (j | θ)2 |
| Run percentage (RP) | 1/n S r (j | θ) |
| Low gray level run emphasis (LGRE) | 1/S S g (i | θ)/i2 |
| High gray level run emphasis (HGRE) | 1/S S i2 g (i | θ) |
p (i, j | θ) is the (i, j)th element of the run length matrix for a direction θ, G is the number of gray levels, R is the longest run, n is the number of pixels in the image, S is the total number of runs in the image.
Figure 3a-e (run-length parameters) and (f) RMS at significant 95% confident interval, (g) femoral neck BMD and (h) trochantar BMD in pre- and postmenopausal women
Figure 4i-m (run-length parameters) and (n) RMS at significant 95% confident interval, (o) femoral neck BMD and (p) trochantar BMD in pre- and postmenopausal women
Subjects classified as ‘normal,’ ‘osteopenia’ and osteoporosis
| Normal | 46.5 ± 8.9 | 19 | 21 | 40 |
| Osteopenia | 55.7 ± 11 | 6 | 16 | 22 |
| Osteoporosis | 63.1 ± 8.7 | 0 | 8 | 8 |
| Total | 25 | 45 | 70 |
SD is standard deviation.
Grouped based on T-score [Femoral neck bone mineral density measured by dual energy X-ray absorptiometry (DXA)]
Mean and standard deviation of the signifi cant texture values and bone mineral density values among the pre- and postmenopausal women
| Pre-menopause (N = 25) | 39.4 ± 3.8 | 0.418 ± 0.05 | 15.83 ± 5.37 | 2387.75 ± 554.34 | 4649.92 ± 1370.6 | 0.337 ± 0.04 | 0.00636 ± 0.00006 | 0.813 ± 0.087 | 0.676 ± 0.075 |
| Postmenopause (N = 45) | 57.9 ± 7.9 | 0.447 ± 04 | 13.35 ± 4.48 | 2687.68 ± 567.7 | 5473.028 ± 1514.7 | 0.363 ± 045 | 0.00651 ± 0.00004 | 0.700 ± 0.098 | 0.575 ± 0.095 |
| Significance | |||||||||
| r-value | - | 0.041 | 0.019 | 0.034 | 0.038 | 0.036 | 0.012 | 0.427 | 0.419 |
Statistical analysis of the Independent Samples t-Test for two groups (pre and postmenopausal women)
| Lower | Upper | ||
|---|---|---|---|
| SRE | 0.020 | −0.0531358 | −0.0046278 |
| LRE | 0.043 | 0.0817635 | 4.8774570 |
| RLN | 0.028 | −1552.5500 | −93.651100 |
| RP | 0.025 | −0.0487566 | −0.0034190 |
| GLN | 0.036 | −580.19290 | −19.663900 |
| LGRE | 0.728 | −0.0019623 | 0.0027952 |
| HGRE | 0.718 | −6.6517999 | 9.6047635 |
| RMS | 0.046 | −0.0003040 | −0.0000029 |
P < 0.05 (significant);
Not significant.